Aitia

Drug discovery is one of humanity's hardest problems — complex biology, massive datasets, and decades of failed trials make the path from idea to treatment painfully slow. Aitia is a biotech company that harnesses Causal AI, Multi-Omics data, and Gemini Digital Twins to cut through this complexity and discover the next generation of breakthrough therapeutics.

By revealing the hidden biological mechanisms of disease that conventional approaches miss, Aitia's platform accelerates both the discovery and development of life-saving drugs — with the mission of making a meaningful impact on patients' lives. For researchers and life science organizations ready to move beyond correlation and find true causation, Aitia represents the leading edge of AI-enabled drug discovery.